Nigerian pharma trade group optimistic on export opportunities

11 September 2017
nigeria-big

The Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMGMAN) has expressed optimism that the recent Executive Orders given by Vice President Yemi Osinbajo on the Support for Local Content in Public Procurement will lead to export of Nigerian medicines abroad, according to a report by Martins Ifjeh in This Day newspaper.

Stating this during the recent 4th Nigerian Pharma Manufacturers Expo in Lagos, PMGMAN chairman Okey Akpa, said the executive order directs the mandatory patronage of locally-manufactured medicines by all government ministries, departments and agencies, adding that the policy is expected to accelerate the growth and development of the local pharmaceutical manufacturing sector.

"Another recent development that demonstrates the efficacy of our new partnership model is the public-private partnership, signed by the federal government with a local firm to produce vaccines in Nigeria. While signing the agreement on behalf of the government, the Minister of Health, Professor Isaac Adewole, stated that the need to ensure medicines' security for the nation was a key factor that underpinned the partnership. There is robust evidence to show that this concept was developed intrinsically by PMGMAN," Mr Akpa added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical